Skip to main content
. Author manuscript; available in PMC: 2014 Feb 5.
Published in final edited form as: Mol Pharm. 2012 Nov 16;9(12):3586–3594. doi: 10.1021/mp3005269

Figure 4.

Figure 4

Biodistribution data in 4T1 tumor-bearing mice at 8 h post-injection of 61Cu-NOTA-K3-VEGF121, or 61Cu-NOTA-K3-VEGF121 after a 100 μg pre-injected dose of K3-VEGF121. n = 4 per group.